Headlines

Workers’ Memorial Week is an occasion to inform workers and their employers of valuable tools and resources that are available to help enhance occupational safety, raise awareness and save lives.

The Institutional Shareholder Services (ISS) ranked Motley Rice in the top half for securities class action settlement recoveries in its 2017 Securities Class Action Services Top 50 report.

A settlement will pay $6.8 million to the family of a Berkeley County father and son who, tragically, were killed July 7, 2015 after an Air Force F-16 Fighting Falcon jet crashed into their single-engine Cessna 150C.

Motley Rice is proud to announce that attorneys Fidelma Fitzpatrick and Jodi Westbrook Flowers have been included in the 2018 issue of The National Law Journal’s Plaintiffs’ Lawyers Trailblazers.

A settlement agreement has been reached in litigation for thousands of South African gold miners and the dependents of workers who developed or will develop tuberculosis and silicosis caused by exposure to silica dust working in gold mines.

We are honored to announce that multiple Motley Rice attorneys in our District of Columbia, South Carolina and West Virginia offices were honored as 2018 Super Lawyers® and Rising Stars.

April 23 to April 30, 2018 marks Workers’ Memorial Week, a national initiative is put on by COSH, a non-profit coalition of local and statewide groups to encourage employers and industry thought leaders to learn from these tragic incidents so that necessary changes can be made.

One person was killed and at least seven others were treated for minor injuries April 17, 2018, after a Southwest Airlines Flight 1380 was forced to make an emergency landing at Philadelphia International Airport due to an apparent engine failure

A Southwest Airlines jet experienced an uncontained engine failure over Pennsylvania, sending shrapnel into the passenger cabin, causing the plane to depressurize and creating what passengers have described as “extreme turbulence.' The most important question is not what occurred – but why.

The FDA imposed “unique” restrictions on sales of permanent contraceptive device Essure due to an “unacceptable” number of women who were being implanted without full knowledge of the risks the device could pose to their health.